Xcout Intel
OmniAb, Inc. competitors & alternatives
The 12 closest competitors and alternatives to OmniAb, Inc. among biotech companies — ranked by similarity to what OmniAb, Inc. actually does, not by market-cap band.
Subscribe to see OmniAb, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About OmniAb, Inc.
OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
OmniAb, Inc. at a glance
OmniAb, Inc. is a biotech company headquartered in EmeryVille, United States. It is publicly listed (OABI) with a market capitalisation of $629.5M. Xcout tracks 33 named people at OmniAb, Inc., including Matthew W Foehr (President, Chief Executive Officer & Director). Xcout recorded 1 job posting from OmniAb, Inc. in the last 90 days.
OmniAb, Inc. leadership
- Matthew W FoehrPresident, Chief Executive Officer & Director
- Amechi NwachukuExecutive VP & Chief Operating Officer
- Kurt A GustafsonExecutive Vice President of Finance & Chief Financial Officer
- Steve LoveChief Financial Officer
- Charles S. BerkmanChief Legal Officer
- John HigginsBoard Chair
27 more named people on record for OmniAb, Inc., with roles, board committees and tenure — see the full roster →
Hiring at OmniAb, Inc.
Xcout recorded 1 job posting from OmniAb, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see OmniAb, Inc.'s hiring signals →
Recent OmniAb, Inc. news
- PartnershipEli Lilly macht OmniAb-Deal: Kooperation für Ionenkanäle mit bis zu 370 Mio. USD Potenzial
2 corporate events on record, with sources — see the full timeline →
Top 12 OmniAb, Inc. competitors
Ranked by semantic similarity — how close each company is to OmniAb, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
Biotechnology
AbbraTech Holdings LLC operates a platform technology focused on recombinant antibody discovery, engineering, and validation. The company targets human diseases such as cancer, immune disorders, and viral infections by developing antibodies for difficult-to-reach drug targets through its proprietary Epivolve technology.
Biotechnology
Adimab is a biotechnology research company headquartered in Lebanon, New Hampshire, that serves as a biopharmaceutical industry partner for therapeutic antibody discovery and engineering.
Similar biotech company
Chiome Bioscience Inc. engages in the research and development of drug discovery technology platforms worldwide. It operates in two segments, Drug Discovery Business and Drug Discovery Support Business. The company offers ADLib System, a technology for generating monoclonal antibodies which is used to generate antibodies for drug discovery research; and Human ADLib System, which converts chicken antibody genes to humanized antibodies. It also provides protein expression and purification services; stable cell line development services for recombinant protein and antibody production; and antibody generation services using the ADLib system. In addition, the company's product pipeline under Phase 1 trial comprises ADCT-701, an anti-dlk1 antibody for treating liver cancer; CBA-1205, an afucosylated anti-dlk1 antibody for liver cancer, lung cancer, and neuroblastoma; and CBA-1535, an anti 5T4/WAIF1 antibody for malignant mesothelioma, small cell lung cancer, non-small cell lung cancer, and triple negative breast cancer (TNBC). Further, its product pipeline under preclinical study includes PCDC, an anti- CDCP1 antibody for lung, colorectal, pancreatic, breast, and ovarian tumors; PTRY, an antibody 5T4/CD3/PD-L1 for treating malignant mesothelioma, small cell lung cancer, non-small cell lung cancer, and TNBC; BMAA, an anti-semphorin3a antibody for treating renal and other diseases; LIV-2008/2008b, an anti-TROP-2 antibody for the treatment of TNBC, lung cancer, and colorectal cancer; PFKR, an anti-CX3CR1 antibody for secondary progressive multiple sclerosis; and PXLR, an anti-CXCL1/2/3/5 antibody for the treatment of gastric, breast, and ovarian tumors. Chiome Bioscience Inc. was incorporated in 2005 and is headquartered in Tokyo, Japan.
Biotechnology
Chimagen Biosciences is a biopharmaceutical company headquartered in Shanghai, China, founded in July 2016. The company specializes in multi-specific antibody therapeutics and built the proprietary TRIAD platform for engineering.
Biotechnology
BigHat Biosciences, Inc. is a for-profit biotechnology company located in California. The firm leverages machine learning and synthetic biology to design next-generation antibody therapies.
Biotechnology
Alloy Therapeutics, Inc. is a biotechnology ecosystem company dedicated to democratizing access to antibodies, multispecifics, and genetic modalities, with offices in Waltham and Boston, Massachusetts.
Biotechnology
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
Biotechnology
Exa Biosciences builds infrastructure solutions designed to power the development of next-generation therapeutic biologics. The company provides foundational support and technologies tailored for organizations and researchers working in the biotherapeutic sector.
Similar biotech company
Dualitas Therapeutics is a privately held biotechnology research company headquartered in South San Francisco, California, that utilizes its DualScreen Bispecific Discovery Engine for proximity engagers.
Biotechnology
Opal Biosciences (operating as Opal Therapeutics) is a biotechnology company that develops patient-derived uterine organoids to model human reproductive biology. The company provides research and drug discovery platforms to help researchers study conditions like endometriosis and uterine fibroids, serving the biotechnology and pharmaceutical research sectors.
Similar biotech company
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of OmniAb, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for OmniAb, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →